QMS Medical Allied Services Ltd

QMS Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

QMS Medical Allied Services Ltd

₹ 104 0.84%
03 Jul - close price
qmsmas.com NSE: QMSMEDI
About

Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]

Key Points

Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.

Website NSE
  • Market Cap ₹ 202 Cr.
  • Current Price ₹ 104
  • High / Low ₹ 114 / 69.0
  • Stock P/E 30.2
  • Book Value ₹ 53.9
  • Dividend Yield 0.48 %
  • ROCE 11.2 %
  • ROE 6.96 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 187 days to 93.0 days

Cons

  • The company has delivered a poor sales growth of 4.53% over past five years.
  • Company has a low return on equity of 10.3% over last 3 years.
  • Promoter holding has decreased over last 3 years: -5.56%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
31.37 25.96 28.64 35.24 32.29 30.37 32.74 39.38 42.38 42.32 41.25 29.54 39.19
28.21 21.30 23.74 30.40 28.34 25.53 27.41 34.04 34.56 36.05 35.12 25.77 34.85
Operating Profit 3.16 4.66 4.90 4.84 3.95 4.84 5.33 5.34 7.82 6.27 6.13 3.77 4.34
OPM % 10.07% 17.95% 17.11% 13.73% 12.23% 15.94% 16.28% 13.56% 18.45% 14.82% 14.86% 12.76% 11.07%
0.19 0.08 0.11 0.15 0.11 0.11 0.09 0.12 0.13 0.15 0.00 0.13 0.07
Interest 0.65 0.59 0.74 0.81 0.99 0.84 1.07 1.31 2.73 1.76 1.73 2.06 2.34
Depreciation 0.37 0.82 0.86 0.88 0.88 0.77 0.83 0.91 0.90 0.76 0.83 0.92 1.01
Profit before tax 2.33 3.33 3.41 3.30 2.19 3.34 3.52 3.24 4.32 3.90 3.57 0.92 1.06
Tax % 33.05% 26.13% 25.22% 25.76% 29.68% 28.44% 25.85% 27.47% 29.17% 31.03% 26.05% 36.96% 27.36%
1.57 2.46 2.56 2.44 1.54 2.40 2.61 2.35 3.07 2.69 2.64 0.58 0.77
EPS in Rs 0.81 1.27 1.33 1.26 0.80 1.24 1.35 1.22 1.59 1.39 1.37 0.30 0.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 52 73 122 146 104 122 145 152
0 47 63 105 130 93 104 121 132
Operating Profit 0 5 10 17 17 11 18 23 20
OPM % 12% 9% 13% 14% 11% 11% 15% 16% 13%
0 0 0 0 1 1 0 0 0
Interest 0 0 1 1 2 2 3 6 8
Depreciation 0 0 0 1 1 1 3 3 4
Profit before tax 0 4 9 15 14 9 12 14 9
Tax % 0% 30% 28% 27% 26% 27% 26% 28% 29%
0 3 6 11 11 6 9 10 7
EPS in Rs 19.15 26.63 26.07 3.31 4.66 5.40 3.46
Dividend Payout % 0% 0% 0% 0% 0% 0% 10% 0% 14%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: 14%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: -9%
3 Years: 2%
TTM: -36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -10%
1 Year: 36%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 10%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.01 0.01 3 4 4 18 18 18 19
Reserves 0 3 6 17 27 53 61 70 85
0 5 12 20 32 26 2 28 91
5 10 12 20 19 22 54 73 25
Total Liabilities 5 18 33 60 82 118 135 189 220
0 0 3 10 8 25 24 22 27
CWIP 0 0 0 0 0 1 2 3 0
Investments 0 0 0 0 0 0 2 48 63
5 18 30 50 75 91 108 115 130
Total Assets 5 18 33 60 82 118 135 189 220

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 0 4 2 -2 -8 1 18 19
0 -0 -4 -8 2 -25 -2 -48 -18
0 0 0 7 0 32 -1 -2 -1
Net Cash Flow 0 0 1 1 1 -1 -1 -32 -0
Free Cash Flow 0 0 1 -6 -2 -9 1 18 19
CFO/OP 200% 34% 44% 34% 11% -47% 26% 98% 105%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 411 56 56 69 105 137 124 104 142
Inventory Days 22,891 76 108 82 80 140 172 176 191
Days Payable 26,124 75 78 73 56 91 90 74 75
Cash Conversion Cycle -2,822 58 86 77 129 187 205 206 258
Working Capital Days -91 20 27 28 57 138 244 224 93
ROCE % 121% 65% 54% 30% 14% 17% 21% 11%

Insights

In beta
Mar 2024 Mar 2025 Mar 2026
Institutional Clients (Pharma Companies)
Clients

Log in to view insights

Please log in to see hidden values.

Login
Number of B2B Health Camps Conducted
Camps
Number of Product SKUs
SKUs
Number of Trained DMLT Field Technicians
DMLTs
Patients Served (Screened / On Digital Platform)
Patients
Serviceable PIN Codes
PIN codes
Total Employees / Professionals
Employees

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 73.67% 68.11% 68.11%
0.71% 1.21% 1.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.60% 1.59%
25.62% 25.12% 25.32% 26.33% 26.33% 26.33% 26.33% 30.28% 30.30%
No. of Shareholders 9251,0431,2131,5861,6951,5191,4891,5641,499

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls